Regeneron (REGN) Tops Q4 EPS by $2.39, Revenues Beat
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $612.50 +0.42%
Revenue Growth %: +3.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +3.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q4 EPS of $12.56, $2.39 better than the analyst estimate of $10.17. Revenue for the quarter came in at $3.41 million versus the consensus estimate of $3.13 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
